Your Article Summary
Biotech Therapies Face Disclosure Requirements
BioPharm, 03/26/09
Biopharmaceutical companies are all too familiar with transparency requirements in regulations governing drug research and marketing. Government agencies and consumer groups are making product price data public to curb inappropriate drug use and reduce national healthcare spending. Manufacturers face a proliferation of state and federal requirements for disclosing payments to researchers and medical professionals, and stiff penalties for failure to comply.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Successful purchase of trait platform with extensive product pipeline
BayNews International, 11/06/09
Cell Therapeutics, Inc.s (CTI) Presentation at BIO Investor Forum to be Webcast
Cell Therapeutics, 11/04/09
Article Search
Sponsor


See Latest Articles


